Trial NCT04486313
Publication Rossignol JF, medRxiv, 2021
Primary outcome on the report: Time from the first dose to sustained response (TSR), a measure of meaningful within-subject change in symptoms

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.